Case Study: TrialGuide Improves Retention in Vaccine Study

March 5, 2020

A simple, intuitive, and regulatory compliant mobile app and reminder system that helps patients and sites stay connected with your study’s goals

Since its launch in 2011, TrialGuide has been used by 18 of the top 20 pharmaceutical companies, 15,000 clinical research sites in over 60 countries and is translated in over 50 languages to support patients across the globe.

Improve the patient experience

A single, mobile touchpoint that integrates study commitments into the patient’s daily life makes it easier to keep up with study requirements.

Increase study completion rates

Patients who use our solution are up to 80% more likely to complete the study, making the effort you spend on recruitment stretch farther.

Decrease patient-related protocol deviations

Patients who use our solution are 85% less likely to have a drug interruption deviation and half as likely to have a procedure-related deviation.

Read more by downloading the case study above.

No Previous Flipbooks

Next Article
Signant Health Unveils its full Conference Line-up for SCOPE 2020
Signant Health Unveils its full Conference Line-up for SCOPE 2020

Subject matter experts, technologists, scientists and executives to advance patient-centric conversations w...